Compass Therapeutics (CMPX)

EBITDA Growth

-19.00%

TTM · Period ending:

CMPX logo

CMPX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-19.00%
CMPX TTM EBITDA YoY % (-43.94% → -19.00%)
High-resolution chart · PNG

CMPX ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Compass Therapeutics EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-18.9969%
-24.5067%
-36.5215%
-40.1943%
-33.2621%
-22.9436%
-17.2889%
-18.3919%
-13.0687%
-18.0717%
-11.9987%
-2.8221%
-24.1424%
53.8874%
54.7887%
49.3987%
58.297%
-195.1647%
-209.6899%
-200.3346%
-223.3586%
-45.6748%
-12.417%
-43.9371%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.